SCHEMBL2291121

SCHEMBL2291121

Cc1c[c]cc(Cl)c1Br

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1928152 0.81
SCHEMBL1355907 0.81
SCHEMBL2283688 0.74
SCHEMBL2288119 0.74
SCHEMBL441450 0.74
SCHEMBL2290807 0.74
SCHEMBL2286065 0.71 KDM4E (0.31)
SCHEMBL2285481 0.70
SCHEMBL2291564 0.70
SCHEMBL2289049 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7989394-B2 Substituted 1-(azolin-2-yl)-amino-2-aryl-1-hetaryl-ethane compounds BASF SE (DE) 2011-08-02 US disclosed
US-20090131256-A1 Substituted 1-(azolin-2-yl)-amino-2-aryl-1-hetaryl-ethane Compounds BASF SE (DE) 2009-05-21 US disclosed
US-5116833-A ANTIBIOTIC C-3 DITHIOACETAL-SUBSTITUTED CARBAPENEM COMPOUNDS, COMPOSITIONS, AND METHODS OF USE THEREOF BRISTOL-MYERS SQUIBB COMPANY (US) 1992-05-26 US disclosed
EP-0481511-A2 Antibiotic C-3 dithioacetal-substituted carbapenem compounds, compositions, and use thereof Bristol-Myers Squibb Company (US) 1992-04-22 EP disclosed